| Year |
Citation |
Score |
| 2023 |
Frosio A, Micaglio E, Polsinelli I, Calamaio S, Melgari D, Prevostini R, Ghiroldi A, Binda A, Carrera P, Villa M, Mastrocinque F, Presi S, Salerno R, Boccellino A, Anastasia L, et al. Unravelling Novel Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights. International Journal of Molecular Sciences. 24. PMID 37894777 DOI: 10.3390/ijms242015089 |
0.336 |
|
| 2023 |
DiFrancesco JC, Ragona F, Murano C, Frosio A, Melgari D, Binda A, Calamaio S, Prevostini R, Mauri M, Canafoglia L, Castellotti B, Messina G, Gellera C, Previtali R, Veggiotti P, et al. A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet. Epilepsia. 64: e222-e228. PMID 37746765 DOI: 10.1111/epi.17777 |
0.336 |
|
| 2022 |
Ghiroldi A, Ciconte G, Creo P, Tarantino A, Melgari D, D'Imperio S, Piccoli M, Cirillo F, Micaglio E, Monasky MM, Frosio A, Locati ET, Vicedomini G, Rivolta I, Pappone C, et al. Alterations of the Sialylation Machinery in Brugada Syndrome. International Journal of Molecular Sciences. 23. PMID 36361941 DOI: 10.3390/ijms232113154 |
0.303 |
|
| 2022 |
Melgari D, Frosio A, Calamaio S, Marzi GA, Pappone C, Rivolta I. T-Type Calcium Channels: A Mixed Blessing. International Journal of Molecular Sciences. 23. PMID 36077291 DOI: 10.3390/ijms23179894 |
0.335 |
|
| 2020 |
Melgari D, Barbier C, Dilanian G, Rücker-Martin C, Doisne N, Coulombe A, Hatem SN, Balse E. Microtubule polymerization state and clathrin-dependent internalization regulate dynamics of cardiac potassium channel: Microtubule and clathrin control of KV1.5 channel. Journal of Molecular and Cellular Cardiology. PMID 32445844 DOI: 10.1016/j.yjmcc.2020.05.004 |
0.412 |
|
| 2020 |
Beuriot A, Eichel CA, Dilanian G, Louault F, Melgari D, Doisne N, Coulombe A, Hatem SN, Balse E. Distinct Calcium/CAlmodulin-dependent Serine protein Kinase domains control cardiac sodium channel membrane expression and focal adhesion anchoring. Heart Rhythm. PMID 31904424 DOI: 10.1016/j.hrthm.2019.12.019 |
0.337 |
|
| 2019 |
Lei CL, Clerx M, Beattie KA, Melgari D, Hancox JC, Gavaghan DJ, Polonchuk L, Wang K, Mirams GR. Rapid Characterization of hERG Channel Kinetics II: Temperature Dependence. Biophysical Journal. PMID 31451180 DOI: 10.1016/J.Bpj.2019.07.030 |
0.547 |
|
| 2018 |
Hancox J, El Harchi A, Melgari D, Zhang H. Investigation of hERG1b influence on hERG channel pharmacology at physiological temperature Journal of Pharmacology and Pharmacotherapeutics. 9: 92. DOI: 10.4103/Jpp.Jpp_158_17 |
0.59 |
|
| 2016 |
Melgari D, Ng GA, Hancox JC. Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium". Circulation. 134: e296-7. PMID 27672201 DOI: 10.1161/Circulationaha.116.023752 |
0.441 |
|
| 2016 |
Beattie K, Melgari D, Hancox J, Mirams G. Exploring temperature-dependence of hERG channel kinetics using sine wave voltage protocols Journal of Pharmacological and Toxicological Methods. 81: 339-340. DOI: 10.1016/J.Vascn.2016.02.017 |
0.587 |
|
| 2015 |
Hancox JC, Melgari D, Dempsey CE, Brack KE, Mitcheson J, Ng GA. hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes. Therapeutic Advances in Drug Safety. 6: 177-9. PMID 26301071 DOI: 10.1177/2042098615595546 |
0.553 |
|
| 2015 |
Melgari D, Brack KE, Zhang Y, El Harchi A, Mitcheson JS, Dempsey CE, Ng GA, Hancox JC. hERG potassium channel inhibition by ivabradine requires channel gating. Journal of Molecular and Cellular Cardiology. 87: 126-8. PMID 26275355 DOI: 10.1016/J.Yjmcc.2015.08.002 |
0.646 |
|
| 2015 |
Melgari D, Zhang Y, El Harchi A, Dempsey CE, Hancox JC. Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide. Journal of Molecular and Cellular Cardiology. PMID 26159617 DOI: 10.1016/J.Yjmcc.2015.06.021 |
0.629 |
|
| 2015 |
Melgari D, Brack KE, Zhang C, Zhang Y, El Harchi A, Mitcheson JS, Dempsey CE, Ng GA, Hancox JC. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine. Journal of the American Heart Association. 4. PMID 25911606 DOI: 10.1161/Jaha.115.001813 |
0.661 |
|
| 2015 |
Hancox JC, Melgari D, Dempsey CE, Brack KE, Mitcheson J, Ng GA. hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes Therapeutic Advances in Drug Safety. 6: 177-179. DOI: 10.1177/2042098615595546 |
0.592 |
|
| 2015 |
Melgari D, Brack KE, Zhang Y, El Harchi A, Mitcheson JS, Dempsey CE, Ng GA, Hancox JC. HERG potassium channel inhibition by ivabradine requires channel gating Journal of Molecular and Cellular Cardiology. 87: 126-128. DOI: 10.1016/j.yjmcc.2015.08.002 |
0.629 |
|
| 2014 |
Melgari D, Du C, El Harchi A, Zhang Y, Hancox JC. Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration. Physiological Reports. 2. PMID 25318749 DOI: 10.14814/Phy2.12165 |
0.572 |
|
| 2014 |
Melgari D, El Harchi A, Dempsey CE, Hancox JC. Sensitivity of Flecainide Inhibition of hERG Channels to Channel Inactivation Biophysical Journal. 106: 138a. DOI: 10.1016/J.Bpj.2013.11.807 |
0.604 |
|
| 2013 |
El Harchi A, Melgari D, Hancox JC. Investigation of the Influence of hERG 1b on hERG Channel Pharmacology Biophysical Journal. 104: 297a. DOI: 10.1016/J.Bpj.2012.11.1655 |
0.588 |
|
| 2012 |
El Harchi A, Melgari D, Zhang YH, Zhang H, Hancox JC. Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K+ Channel Plos One. 7. PMID 23300672 DOI: 10.1371/Journal.Pone.0052451 |
0.605 |
|
| Show low-probability matches. |